Biotechnology

 

Click the highlighted date for further information.

Conferences in 2017

June 25-30, 2017 (17AL) CONFERENCE ON IONIC LIQUIDS VII (COIL 7) (Mont Tremblant, Canada)
C. Robelin, Ecole Polytechnique de Montreal; J. Clyburne, Saint Mary’s University; L. Rehmann, Western University;H. Alper, University of Ottawa- Coordinator

September 17-21, 2017 (17AA) INTEGRATED CONTINUOUS BIOMANUFACTURING III (Cascais, Portugal)
(S. Farid, University College London; C. Goudar, Amgen; P. Alves, IBET; V. Warikoo, Axcella Health, Inc.)

Sept 24-28, 2017 (17AE) ENZYME ENGINEERING XXIV (Toulouse, France)
P. Monsan, Toulouse White Biotechnology; M. Remaud-Simeon, LISBP-INSA, University of Toulouse

TBA, 2017 (17AQ) FAIRNESS IN THE DELIVERY OF HEALTH CARE: AN EXAMINATION OF PRICING, TECHNOLOGY AND PEOPLE ISSUES (TBA)
(R. Spier, Univ. of Surrey (Emeritus); B. Buechner, CELLS (Germany), and Indiana University for Bioethics; A. Caplan, New York University; M. Feinberg, Merck Sharp and Dohme; N. Hoppe, CELLS; A. Blasimme, INSERM Toulouse)

2018

March 4-8, 2018 (18AK) MICROBIAL ENGINEERING (Santa Ana Pueblo, New Mexico, USA)
EKeshavarz-Moore, University College London; B. Buckland, BiologicB

May 6-11, 2018 (18AC) CELL CULTURE ENGINEERING XVI (Tampa, Florida, USA)
(A. Robinson, Tulane University; R. Venkat, MedImmune; E. Schaefer, J&J Janssen)

June 5-9, 2018 (18AH) NANOTECHNOLOGY IN MEDICINE II: BRIDGING TRANSLATIONAL in vitro AND in vivo INTERFACES (Albufeira, Portugal)
M.O. Sullivan, University of Delaware; J. Sznitman, Technion – Israel Institute of Technology; P. Decuzzi, Italian Institute of Technology; S. Kidambi, University of Nebraska, Lincoln;  L. Eniola-Adefeso, University of Michigan

June 17-22, 2018 (18AA) VACCINE TECHNOLOGY VII (Mont Tremblant, Quebec, Canada)
(A.Kamen, McGill University; T. Mukhopadhyay, University College London; N. Garcon, Bioaster; C. Lutsch, Sanofi Pasteur)

Summer 2018 TBA (18AD) COLLOIDAL, MACROMOLECULAR AND BIOLOGICAL GELS II(TBA)
S. Amin, L’Oreal; S. Khan, North Carolina State University

TBA, 2018(18AG) MICROBIOME ENGINEERING (TBA)
(J. Aunins, Seres Health)

2019

Jan 27-31, 2019 (19AT) ADVANCING MANUFACTURE OF CELL AND GENE THERAPIES VI (Coronado, CA)
D.Baksh, GE Healthcare; I. Wall, University College London; R. Rietze, Novartis